Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in early rheumatoid arthritis: 2-year quality-of-life results of the randomised, controlled, SWEFOT trial.

Johan Karlsson, Martin Neovius, Jan-Åke Nilsson, Ingemar Petersson, Johan Bratt, Ronald F van Vollenhoven, Sofia Ernestam, Pierre Geborek

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskriftPeer review

18 Citeringar (SciVal)

Sökresultat